Component 1 (PC1) accounted for 57% of the variance and was associated with core AD biomarkers: Aβ40/Aβ42, p-Tau181, t-tau, and the synaptic markers neurogranin and GAP-43. This evidence concerns the gene NRGN and Alzheimer disease.